GFA
AGIO icon

Gallagher Fiduciary Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
11,095
+18
+0.2% +$546 0.01% 239
2026
Q1 		$375K Sell
11,077
-168
-1% -$4.76K 0.01% 223
2025
Q4 		$306K Sell
11,245
-15
-0.1% -$526 0.01% 269
2025
Q3 		$452K Sell
11,260
-213
-2% -$8.01K 0.02% 183
2025
Q2 		$382K Sell
11,473
-1,357
-11% -$41.1K 0.01% 219
2025
Q1 		$376K Buy
12,830
+1,720
+15% +$57.1K 0.01% 193
2024
Q4 		$365K Buy
11,110
+788
+8% +$37K 0.07% 191
2024
Q3 		$459K Buy
10,322
+3,382
+49% +$154K 0.09% 127
2024
Q2 		$299K Buy
+6,940
New +$250K 0.07% 159

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Gallagher Fiduciary Advisors's AGIO Position: Q2 2026 in Review

Gallagher Fiduciary Advisors increased its Agios Pharmaceuticals (AGIO) stake by 0.16% in Q2 2026, buying an estimated $546 and bringing the position to 11,095 shares worth $412K. The position accounts for 0.01% of the portfolio, ranked #239.

Gallagher Fiduciary Advisors first reported a position in AGIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $459K in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Gallagher Fiduciary Advisors held 11,095 shares of Agios Pharmaceuticals worth $412K as of Q2 2026.
  • Gallagher Fiduciary Advisors bought 18 Agios Pharmaceuticals shares in Q2 2026, an estimated $546.
  • Agios Pharmaceuticals made up 0.01% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #239 holding.
  • Gallagher Fiduciary Advisors first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Gallagher Fiduciary Advisors's Agios Pharmaceuticals position peaked at $459K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.